ADC Therapeutics SA (ADCT) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Yarrow Bioscience (YARW) has outperformed ADC Therapeutics SA (ADCT) over the past year, losing 7.5% versus a loss of 67.1%. Over five years, ADCT leads with a -94.4% price change compared with -98.3% for YARW. ADC Therapeutics SA is the larger company by market cap ($203.0 million vs $184.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | YARW |
|---|---|---|
| Share price | $1.59 | $19.87 |
| Market cap | $202.99M | $184.88M |
| 1-day change | +11.97% | +5.83% |
| YTD return | -59.77% | -35.26% |
| 1-year return | -67.05% | -7.51% |
| 5-year return | -94.42% | -98.29% |
| EPS (TTM) | $-0.60 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $46.95 |
| 52-week low | $0.78 | $16.05 |
| Distance from 52-week high | -68.07% | -57.68% |
| Analyst consensus | none | none |
| Avg. price target upside | +109.43% | +186.86% |
| Average volume | 1.35M | 87.51K |
| Shares outstanding | 127.67M | 9.30M |
| Employees | 188 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- YARW has outperformed ADCT by 59.5 percentage points over the past year.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
ADCT vs YARW FAQ
Which is bigger, ADC Therapeutics SA or Yarrow Bioscience?
ADC Therapeutics SA (ADCT) is larger, with a market capitalization of $202.99M compared with $184.88M for Yarrow Bioscience (YARW).
Which stock has performed better over the past year, ADCT or YARW?
YARW returned -7.51% over the past 12 months, compared with -67.05% for ADCT (price return, excluding dividends). Past performance does not predict future results.
Are ADC Therapeutics SA and Yarrow Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.